Raub Brock Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Raub Brock Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$286K	Hold	570	–	–	0.08%	36
2026 Q1	$280K	Hold	570	–	–	0.07%	37
2025 Q4	$330K	Sell	570 -30	-5%	-$17K	0.07%	35
2025 Q3	$291K	Hold	600	–	–	0.06%	35
2025 Q2	$243K	Hold	600	–	–	0.05%	36
2025 Q1	$299K	Hold	600	–	–	0.07%	36
2024 Q4	$312K	Hold	600	–	–	0.07%	36
2024 Q3	$371K	Hold	600	–	–	0.08%	34
2024 Q2	$332K	Hold	600	–	–	0.07%	35
2024 Q1	$349K	Hold	600	–	–	0.07%	35
2023 Q4	$318K	Hold	600	–	–	0.07%	56
2023 Q3	$304K	Hold	600	–	–	0.06%	53
2023 Q2	$313K	Hold	600	–	–	0.06%	53
2023 Q1	$346K	Hold	600	–	–	0.07%	50
2022 Q4	$330K	Hold	600	–	–	0.07%	47
2022 Q3	$304K	Hold	600	–	–	0.06%	49
2022 Q2	$326K	Hold	600	–	–	0.06%	47
2022 Q1	$354K	Buy	+600	New	+$345K	0.06%	51

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Raub Brock Capital Management's TMO Position: Q2 2026 in Review

Raub Brock Capital Management held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 570 shares worth $286K. The position accounts for 0.08% of the portfolio, ranked #36.

Raub Brock Capital Management first reported a position in TMO in Q1 2022 and has held it in 18 quarters since. The position peaked at $371K in Q3 2024. 2,617 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Raub Brock Capital Management held 570 shares of Thermo Fisher Scientific worth $286K as of Q2 2026.
Raub Brock Capital Management left its Thermo Fisher Scientific share count unchanged in Q2 2026.
Thermo Fisher Scientific made up 0.08% of Raub Brock Capital Management's portfolio in Q2 2026, its #36 holding.
Raub Brock Capital Management first reported a position in Thermo Fisher Scientific in Q1 2022 and has held it in 18 quarters since.
Raub Brock Capital Management's Thermo Fisher Scientific position peaked at $371K in Q3 2024.
2,617 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Raub Brock Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.